Low-dose IL-2 for SLE

被引：0
|
作者：
Thorley, Jennifer
机构：
来源：
LANCET RHEUMATOLOGY | 2019年 / 1卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E143 / E143
页数：1
相关论文
共 50 条
  • [1] Mechanisms of action of low-dose IL-2 restoration therapies in SLE
    Ballesteros-Tato, Andre
    Papillion, Amber
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2019, 61 : 39 - 45
  • [2] Low-Dose IL-2 in the Treatment of Lupus
    Masayuki Mizui
    George C. Tsokos
    [J]. Current Rheumatology Reports, 2016, 18
  • [3] Low-Dose IL-2 in the Treatment of Lupus
    Mizui, Masayuki
    Tsokos, George C.
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2016, 18 (11)
  • [4] Local low-dose IL-2 therapy
    Den Otter, W
    Balemans, L
    Battermann, JJ
    Bernsen, MR
    Cadee, JA
    Dobrowolski, Z
    Everse, LA
    Fiszer-Maliszewska, L
    Gavhumende, R
    De Groot, JW
    De Groot, K
    Hennink, WE
    Hill, FWG
    Jurgenliemp-Schulz, I
    Klein, WR
    Koten, JW
    Maas, RA
    Steerenberg, P
    Stewart, R
    Zembala, M
    [J]. HEPATO-GASTROENTEROLOGY, 1999, 46 : 1280 - 1286
  • [5] EFFICACY OF LOW-DOSE IL-2 IN PATIENTS WITH MYOSITIS
    Wang, X. M.
    Zhang, J. X.
    Chai, P. H.
    Li, Y. Z.
    Su, Q. Y.
    Yu, Q.
    He, P. F.
    Li, X.
    Zhang, S. X.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1671 - 1672
  • [6] Low-dose IL-2 therapy for autoimmune diseases
    Collison J.
    [J]. Nature Reviews Rheumatology, 2019, 15 (1) : 2 - 2
  • [7] Low-dose IL-2 mitigates glucocorticoid-induced Treg impairment and promotes improvement of SLE
    Haotian Zhou
    Xiaozhen Zhao
    Ruijun Zhang
    Miao Miao
    Wenwen Pei
    Zijun Li
    Yimin Li
    Jing He
    Zhanguo Li
    Xiaolin Sun
    [J]. Signal Transduction and Targeted Therapy, 8
  • [8] Low-dose IL-2 mitigates glucocorticoid-induced Treg impairment and promotes improvement of SLE
    Zhou, Haotian
    Zhao, Xiaozhen
    Zhang, Ruijun
    Miao, Miao
    Pei, Wenwen
    Li, Zijun
    Li, Yimin
    He, Jing
    Li, Zhanguo
    Sun, Xiaolin
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [9] LOW-DOSE IL-2 THERAPY IN SLE: RESULTS FROM A COMBINED PHASE I/IIA CLINICAL TRIAL
    Humrich, J.
    Von Spee-Mayer, C.
    Siegert, E.
    Bertolo, M.
    Rose, A.
    Abdirama, D.
    Enghard, P.
    Hiepe, F.
    Radbruch, A.
    Burmester, G. -R.
    Riemekasten, G.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (04) : S13 - S13
  • [10] INCREASED PERIPHERAL CD8+T CELL RESPONSES IN SLE BY LOW-DOSE IL-2 TREATMENT
    Zhang, R.
    He, J.
    Sun, X.
    Zou, Y.
    Gan, Y.
    Li, Z.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1065 - 1065
12345